Takeda Pharmaceutical Co. Ltd. - Cash Ratio

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.

The item "Cash-Ratio" stands at 0.3457 as of 09/30/2025.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Cash Ratio" stands at 0.3457. This represents an increase of 114.29 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -3.93 percent compared to the value the year prior.
The 1 year change in percent is -3.93.
The 3 year change in percent is 3.59.

The Serie's long term average value is 0.248. It's latest available value, on 09/30/2025, is 39.53 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2023, to it's latest available value, on 09/30/2025, is +173.60%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -12.70%.